Tina Susan Nova

Companies

• Aurinia Pharmaceuticals Inc.Board member May 16, 2025 to now¹
• Azenta Life SciencesBoard member Feb 7, 2023 to now²
• Exagen Inc.Board member Sep 18, 2019 to now³
• Exagen Inc.Chair Jun 20, 2023 to Jun 20, 2023⁴
• Arena PharmaceuticalsBoard member Aug 1, 2006 to Mar 11, 2022⁵
• VERACYTE, INC.President Jan 13, 2022 to Mar 7, 2022⁶
• VERACYTE, INC.Board member Nov 16, 2015 to Jun 9, 2020⁷
• OpGen (United States)Board member May 1, 2017 to Sep 3, 2019⁸
• NanoString TechnologiesBoard member May 1, 2014 to May 1, 2014⁹
• Adamis Pharmaceuticals CorporationBoard member Feb 11, 2011 to Oct 17, 2013¹⁰

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VVERACYTE, INC. VCYT76,988 shares¹¹$3.5M at $45.27Mar 3, 2022
• Azenta Life Sciences AZTA15,772 shares¹²$556.9K at $35.31Feb 6, 2026
• Arena Pharmaceuticals ARNA0 shares¹³Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 6, 2026Granted 5,663 shares at $27.85 of Azenta Life Sciences¹²
• Feb 7, 2025Granted 4,040 shares at $52.32 of Azenta Life Sciences¹⁴
• Feb 12, 2024Granted 2,465 shares at $65.93 of Azenta Life Sciences¹⁵
• Feb 13, 2023Granted 3,604 shares of Azenta Life Sciences¹⁶
• Mar 11, 2022Other 3,067 shares of Arena Pharmaceuticals¹³
• Mar 11, 2022Other 17,776 shares of Arena Pharmaceuticals¹³
• Mar 3, 2022Granted 56,546 shares of VERACYTE, INC.¹¹
• Mar 2, 2022Shares withheld for tax 10,695 shares at $27.84 of VERACYTE, INC.¹⁷